Owens & Minor Analyst Ratings
Baird Maintains Neutral on Owens & Minor, Lowers Price Target to $20
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Owens & Minor (OMI) and Illumina (ILMN)
Owens & Minor Analyst Ratings
Baird Maintains Neutral on Owens & Minor, Lowers Price Target to $24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Idexx Laboratories (IDXX) and CytomX Therapeutics (CTMX)
Citi: Maintains Owens & Minor (OMI.US) rating, adjusted from neutral to neutral, and adjusted the target price from $24.00 to $28.00.
Owens & Minor Analyst Ratings
Citigroup Maintains Neutral on Owens & Minor, Raises Price Target to $28
Analysts' Opinions Are Mixed on These Healthcare Stocks: Owens & Minor (OMI), Bruker (BRKR) and Gilead Sciences (GILD)
Baird: Maintaining the Owens & Minor (OMI.US) rating, adjusted from neutral to neutral, and adjusted the target price from $24.00 to $28.00.
Owens & Minor Analyst Ratings
Baird Maintains Neutral on Owens & Minor, Raises Price Target to $28
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Owens & Minor (OMI) and Warby Parker (WRBY)
Critical Insights From Owens & Minor Analyst Ratings: What You Need To Know
UBS Adjusts Owens & Minor Price Target to $27 From $26, Maintains Buy Rating
Owens & Minor Analyst Ratings
Maintaining Sell Rating on Owens & Minor: Navigating Short-Term Hurdles While Investing for Long-Term Growth
UBS Maintains Buy on Owens & Minor, Lowers Price Target to $26
Owens & Minor Analyst Ratings